摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2Z)-2-ethyl-3-phenylprop-2-enal | 351041-63-9

中文名称
——
中文别名
——
英文名称
(2Z)-2-ethyl-3-phenylprop-2-enal
英文别名
(Z)-α-ethylcinnamaldehyde;trans-α-Aethyl-zimtaldehyd;Butanal, 2-(phenylmethylene)-;(2Z)-2-benzylidenebutanal
(2Z)-2-ethyl-3-phenylprop-2-enal化学式
CAS
351041-63-9
化学式
C11H12O
mdl
——
分子量
160.216
InChiKey
BOCRJYUZWIOMOJ-NTMALXAHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    271.1±9.0 °C(Predicted)
  • 密度:
    0.997±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    三正丁胺苯甲醛四氯化钛 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 1.17h, 以31%的产率得到(2Z)-2-ethyl-3-phenylprop-2-enal
    参考文献:
    名称:
    Ram; Charles, Journal of Chemical Research - Part S, 2000, # 11, p. 540 - 542
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • A general route to α-alkyl (E)-α,β-unsaturated aldehydes
    作者:Nour Lahmar、Jamaa Aatar、Taïcir Ben Ayed、Hassen Amri、Moncef Bellassoued
    DOI:10.1016/j.jorganchem.2006.03.015
    日期:2006.6
    Bis(trimethylsilyl)-tert-butylaldimines 3 react with aldehydes in the presence of zinc bromide at room temperature to give, after hydrolysis, the desired α-alkyl α,β-ethylenic aldehydes in good yield and with very high E stereoselectivity. The reaction was believed to proceed via the α-silyl β-siloxyimines 4.
    在室温下,在溴化锌存在下,双(三甲基甲硅烷基)-叔丁基亚胺3与醛反应,水解后以高收率和非常高的E立体选择性得到所需的α-烷基α,β-乙烯醛。据信该反应通过α-甲硅烷基β-甲硅烷氧基亚胺4进行。
  • SULFONYLPYRAZOLE AND SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS
    申请人:Van Loevezijn Arnold
    公开号:US20080311179A1
    公开(公告)日:2008-12-18
    This invention concerns compounds of the general formula (1). and derivatives thereof, which are antagonists of 5-HT 6 receptors, wherein the symbols have the meanings given in the description. The invention also concerns methods for the preparation of these compounds, to novel intermediates useful for their synthesis, and to uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in treating at least on disease or condition chosen from Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, binge eating disorders, panic attacks, akathisia, attention deficit hyperactivity disorder, attention deficit disorder, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, disorders associated with spinal trauma or head injury, hydrocephalus, functional bowel disorder, Irritable Bowel Syndrome, obesity and type-2 diabetes.
    本发明涉及通式(1)的化合物及其衍生物,它们是5-HT6受体拮抗剂,其中符号的含义如说明书所示。本发明还涉及制备这些化合物的方法,对于其合成有用的新型中间体,以及这些化合物和组合物的用途,特别是将它们用于向患者施用以达到治疗帕金森病、亨廷顿舞蹈症、精神分裂症、焦虑、抑郁症、躁郁症、精神病、癫痫、强迫症、情绪障碍、偏头痛、阿尔茨海默病、与年龄相关的认知衰退、轻度认知障碍、睡眠障碍、进食障碍、厌食症、贪食症、暴食症、惊恐发作、不安定症、注意力缺陷多动障碍、注意力缺陷障碍、戒断可卡因、乙醇、尼古丁或苯二氮平的滥用、疼痛、与脊髓损伤或头部损伤有关的疾病、脑积水、功能性肠道障碍、肠易激综合征、肥胖症和2型糖尿病等至少一种疾病或症状的治疗效果。
  • Asymmetric Oxidative Lactonization of Enynyl Boronates
    作者:Kezhuo Zhang、Chenchen Li、Yining Jia、Wanxiang Zhao
    DOI:10.1002/anie.202209004
    日期:2022.10.10
    We present herein the first oxidation of enynyl boronates for the synthesis of γ-lactones, including spiro-, and fused-butanolides as well as butenolides that are prevalent in nature products and bioactive molecules. The asymmetric version of this oxidation was also achieved in the presence of chiral ketone and Oxone. This process successively involves the oxidation of C(sp)−B bond, the epoxidation
    我们在此提出了用于合成γ-内酯的烯基硼酸酯的第一次氧化,包括螺环和稠合丁内酯以及在天然产物和生物活性分子中普遍存在的丁烯内酯。这种氧化的不对称形式也在手性酮和 Oxone 的存在下实现。该过程依次涉及 C(sp)-B 键的氧化、C-C 双键的环氧化和内酯化。
  • SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS
    申请人:Solvay Pharmaceuticals B.V.
    公开号:EP2069310A2
    公开(公告)日:2009-06-17
  • SULFONYLPYRAZOLINE-1-CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS
    申请人:Abbott Healthcare Products B.V.
    公开号:EP2069310B1
    公开(公告)日:2011-12-14
查看更多